Skip to main content
. 2021 Sep 7;22:302. doi: 10.1186/s12882-021-02483-y

Table 4.

Odds Ratio and 95 % confidence intervals of the association between liver fibrosis score (FIB-4) and low eGFR (eGFR calculated from CKD-EPI cystatin C equation) and increased urine albumin-to-creatinine ratio (UACR)

Regression models Weighted % (SD) Low eGFR Increased UACR
OR and 95 %CI OR and 95 %CI
Unadjusted model
  Low FIB-4 86.5 (0.45) 1.00 1.00
  Moderate FIB-4 12.5 (0.43) 7.90 (5.73, 10.89) 1.87 (1.58, 2.23)
  High FIB-4 1.0 (0.13) 5.38 (1.99, 14.53) 4.46 (2.82, 7.05)
Model 1
  Low FIB-4 86.5 (0.45) 1.00 1.00
  Moderate FIB-4 12.5 (0.43) 1.37 (0.98, 1.93) 1.12 (0.92, 1.36)
  High FIB-4 1.0 (0.13) 0.67 (0.24, 1.90) 2.47 (1.54, 3.96)
Model 2
  Low FIB-4 86.5 (0.45) 1.00 1.00
  Moderate FIB-4 12.5 (0.43) 1.35 (0.96, 1.90) 1.18 (0.97, 1.43)
  High FIB-4 1.0 (0.13) 0.65 (0.23, 1.83) 2.62 (1.63, 4.20)
Model 3
  Low FIB-4 86.5 (0.45) 1.00 1.00
  Moderate FIB-4 12.5 (0.43) 1.31 (0.93, 1.83) 1.15 (0.94, 1.41)
  High FIB-4 1.0 (0.13) 0.60 (0.21, 1.75) 2.54 (1.56, 4.13)

Liver fibrosis score (FIB-4): low (FIB-4 < 1.3), moderate (FIB-4: 1.3–2.67), and high (FIB-4 > 2.67)

Low eGFR defined as eGFR < 60 ml/min/1.73 m2

Increased UACR defined as UACR > 17 mg/g in men and > 25 mg/ g in women

Model 1 adjusted for age, sex, Hispanic/Latino background, and study site

Model 2 adjusted for age, sex, Hispanic/Latino background, study site, and metabolic syndrome

Model 3 adjusted for age, sex, Hispanic/Latino background, study site, metabolic syndrome, education attainment, alcohol consumption, cigarette smoking, having health insurance, use of angiotensin converting enzyme inhibitors/angiotensin receptor blockers, and corticosteroids